US20110021733A1 - Intraocular lenses essentially free from glistenings - Google Patents
Intraocular lenses essentially free from glistenings Download PDFInfo
- Publication number
- US20110021733A1 US20110021733A1 US12/895,768 US89576810A US2011021733A1 US 20110021733 A1 US20110021733 A1 US 20110021733A1 US 89576810 A US89576810 A US 89576810A US 2011021733 A1 US2011021733 A1 US 2011021733A1
- Authority
- US
- United States
- Prior art keywords
- monomer
- hydrogen
- ophthalmic device
- polymer composition
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 [1*]C(=C)C(=O)OCC[2*] Chemical compound [1*]C(=C)C(=O)OCC[2*] 0.000 description 7
- XEDXBHWUEPBNEK-UHFFFAOYSA-N C.C.C.C.C.C=CC(=O)OC(COC1=CC=CC=C1)COC1=CC=CC=C1.C=CC(=O)OC(CSC1=CC=CC=C1)CSC1=CC=CC=C1.C=CC(=O)OC1=CC=C(OC2=CC=CC=C2)C=C1.C=CC(=O)OCC(COC1=CC=CC=C1)OC1=CC=CC=C1.C=CC(=O)OCC(CSC1=CC=CC=C1)SC1=CC=CC=C1 Chemical compound C.C.C.C.C.C=CC(=O)OC(COC1=CC=CC=C1)COC1=CC=CC=C1.C=CC(=O)OC(CSC1=CC=CC=C1)CSC1=CC=CC=C1.C=CC(=O)OC1=CC=C(OC2=CC=CC=C2)C=C1.C=CC(=O)OCC(COC1=CC=CC=C1)OC1=CC=CC=C1.C=CC(=O)OCC(CSC1=CC=CC=C1)SC1=CC=CC=C1 XEDXBHWUEPBNEK-UHFFFAOYSA-N 0.000 description 1
- OANLLRVFXHABSM-UHFFFAOYSA-N C=C(C)C(=O)OC[Y][Ar] Chemical compound C=C(C)C(=O)OC[Y][Ar] OANLLRVFXHABSM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Definitions
- the present invention relates to intraocular lenses manufactured from copolymers comprising a single high refractive index monomer, wherein the intraocular lenses are essentially free from glistenings.
- IOL intraocular lenses
- Hydrogels have a relatively low refractive index which makes them less desirable materials because of the thicker lens optic that is necessary to achieve a given refractive power.
- Silicones have a higher refractive index than hydrogels, but tend to unfold explosively after being placed in the eye in a folded position. Explosive unfolding can potentially damage the corneal endothelium and/or rupture the natural lens capsule.
- Acrylic polymers are currently the material of choice since they typically have a high refractive index and unfold more slowly or controllably than silicone materials.
- IOL material A further requirement for IOL material is that rolling the lens does not induce tears or wrinkles so that after release of the lens from the cartridge nozzle the lens unfolds in a controlled way to its pre-rolled dimensions without its optical quality being compromised.
- the material must also be stiff enough such that thin high refractive index lenses do not deform when residing in the eye. After all, lenses must remain flat to retain their optical properties.
- a known method for manufacturing IOL's comprises polymerization of the acrylic monomer composition in open moulds where after the raw IOL is further mechanically processed by lathing, drilling, grinding and the like.
- Such methods wherein in particular closed castmoulds are employed might give rise to the formation of vacuoles filled with air or gas in the polymerised material.
- Such vacuoles are in particular formed when thermal free radical initiators such as azo initiators are used that form gases as byproducts.
- these vacuoles Upon implantation of the IOL, these vacuoles are hydrated thereby giving rise to the formation of white dots due to reflection of light, a phenomenon known in the art as “glistenings”. In fact, these vacuoles containing moisture have a refractive index that is different from that of the IOL material.
- a solution for this problem that is provided by the prior art is employing an acrylate monomer composition comprising at least one hydrophobic, high refractive index IOL-forming monomer in conjunction with a small amount of a hydrophilic monomer.
- an acrylate monomer composition comprising at least one hydrophobic, high refractive index IOL-forming monomer in conjunction with a small amount of a hydrophilic monomer.
- U.S. Pat. No. 5,693,095 discloses acrylic monomer compositions comprising a hydrophilic monomer, e.g. 2-hydroxyethyl acrylate, and a high refractive index, IOL-forming, hydrophobic aryl acrylic monomer having the general formula:
- the acrylic monomer compositions further comprise a crosslinker such as 1,4-butanediol diacrylate.
- the polymerization of the acrylic monomer composition is preferably thermally initiated by using peroxy free radical initiators.
- the polymerized materials are said to be substantially free of glistenings.
- U.S. Pat. Nos. 6,140,438 and 6,326,448 disclose an acrylic monomer composition comprising an aromatic ring containing (meth)acrylate monomer (A) of the formula:
- R 1 is hydrogen or methyl
- n is an integer of 0-5
- X is a direct bond or oxygen
- R 2 is an optionally substituted aromatic group
- a hydrophilic monomer (B) an alkyl(meth)acrylate monomer (C) wherein the alkyl group has 1-20 carbon atoms
- a crosslinker (D) The polymerization can be conducted by any conventional method, i.e. thermally by using azo or peroxide initiators or by irradiation with electromagnetic waves such as UV.
- the polymerized material has a water absorptivity of 1.5 to 4.5 wt. % and has an improved transparency.
- the polymerized materials are further mechanically processed into IOL's.
- U.S. Pat. Nos. 6,329,485 and 6,657,032 disclose an acrylic monomer composition comprising a high refractive index aromatic acrylate monomer, a hydrophilic monomer in an amount higher than that of the high refractive index aromatic acrylate monomer, and a crosslinker.
- the polymerization is preferably conducted by thermal initiation in the presence of azo or peroxide initiators, preferably the azo initiator 2,2′-azobis(isobutyronitril). After polymerization, the polymerized materials are further mechanically processed as described above to form IOL's.
- the prior art discussed above all employ acrylic monomer compositions comprising at least two IOL-forming monomers, i.e. a hydrophobic monomer and a hydrophilic monomer, and a crosslinker not only to improve the hydrophilicity of the polymerised material, but also to adjust the glass transition temperature to around ambient temperature or below (as otherwise the lenses cannot be folded without damaging the lens).
- a crosslinker not only to improve the hydrophilicity of the polymerised material, but also to adjust the glass transition temperature to around ambient temperature or below (as otherwise the lenses cannot be folded without damaging the lens).
- this has the disadvantage that the refractive index is also lowered which is obviously undesired.
- A is hydrogen or methyl
- B is —(CH 2 ) m — wherein m is an integer of 2-5
- Y is a direct bond or oxygen
- C is —(CH 2 ) n — wherein w is an integer of 0 or 1
- Ar is phenyl.
- the IOL material is made from these monomers only and a cross-linking monomer.
- the refractive index is at least 1.50
- de glass transition temperature is preferably below 25° C. and the elongation is at least 150%.
- US 2005/0049376 discloses curable (meth)acrylate compositions suitable for optical articles and in particular for light management films. Apart from a high refractive index, these compositions when cured have desirably a high glass transition temperature for shape retention during storage and use of the light management films. Tables 7 and 8 disclose glass transition temperatures of 41°-62° C.
- the refractive index of a composition made of 1,3-bis(thiophenyl)propane-2-yl acrylate and the diacrylate of tetrabromo bisphenol A diepoxide has a refractive index as high as 1.6016 (Example 14). Although generally having a high refractive index, the compositions are obviously unsuitable for IOL applications because of their high glass transition temperatures.
- U.S. Pat. No. 6,015,842 discloses a method for preparing a foldable, acrylic, high refractive index ophthalmic material from a composition comprising a hydrophilic crosslinker, e.g. polyethyleneoxide di(meth)acrylate, one or more hydrophilic monomers, a UV absorbing chromophore and a benzoyl phosphine oxide photoinitiator which can be activated by blue light having a wave length in the range of 400-500 nm.
- a hydrophilic crosslinker e.g. polyethyleneoxide di(meth)acrylate
- one or more hydrophilic monomers e.g. polyethyleneoxide di(meth)acrylate
- a UV absorbing chromophore e.g., a UV absorbing chromophore
- a benzoyl phosphine oxide photoinitiator which can be activated by blue light having a wave length in the range of 400-500
- US 2005/0055090 discloses an intraocular lens that is made from a high refractive index monomer, a photoinitiator that can be activated by blue light having a wave length of above 500 nm.
- the high refractive index monomer is for example 2-ethylphenoxy (meth)acrylate and 2-ethylthiophenyl (meth)acrylate.
- the present invention relates to a method for manufacturing an intraocular lens, wherein an acrylic monomer composition containing a single high refractive index monomer according to formula (I):
- R 1 is H or CH 3 ;
- R 2 is a C 1 -C 3 alkylene or —C 1 -C 3 alkylene)-Y—(C 1 -C 3 alkylene)-;
- Y is O or S
- R 3 is C 6 -C 18 aryl or heteroaryl
- R 4 is H or linear or branched C 1 -C 6 alkyl
- the present invention also relates to an intraocular lens that is obtainable according the method of the invention.
- the method according to the invention can conveniently be performed in a closed castmould and provides ready-to-use IOL's, i.e. that minimal (e.g. only cutting) or no further mechanical processing is necessary.
- the IOL's formed by the method according to the present invention are essentially free from glistenings.
- a test for evaluating the presence of glistenings is disclosed in U.S. Pat. No. 5,693,095, incorporated by reference for the US patent practice.
- alkyl group is to be understood as a linear or branched alkyl group e.g. having 1 to 6 carbon atoms.
- alkyl groups include methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 1-pentyl, 1-hexyl and the like.
- alkylene group is to be understood as a linear or branched alkylene group having 1 to 3 carbon atoms, e.g. 1,3-propanediyl (—CH 2 —CH 2 —CH 2 —) and ethanediyl (—CH 2 —CH 2 —).
- An aryl group is to be understood as an aryl group having 6 to 18 carbon atoms.
- the aryl group may be substituted or unsubstituted. If the aryl group is substituted, it is preferred that they aryl group is substituted with 1 to 5 substituents, preferably 1 to 3 substituents, selected from the group consisting of halo, C 1 -C 4 alkyl, C 1 -C 4 alkyl-O—, C 1 -C 4 alkyl-S—, C 1 -C 4 haloalkyl, C 1 -C 4 haloalkyl-O— and C 1 -C 4 haloalkyl-S—.
- the aryl group may also be an annelated aryl group such as naphtyl and anthracenyl.
- a heteroaryl group is to be understood as an aryl group having 6 to 18 carbon atoms and comprising one to three, preferably one to two heteroatoms selected from the group consisting of nitrogen, oxygen and sulphur.
- Suitable examples of heteroaryl groups include imidazolyl, furanyl, isoxazolyl, pyranyl, pyrazinyl, pyrazolyl, pyridyl and the like.
- the heteroaryl group may also be an annelated heteroaryl group such as indolyl and benzothiazolyl.
- Y is S.
- R 4 is substituted, it is preferably substituted by C 1 -C 4 alkyl, C 1 -C 4 alkyl-O— or C 1 -C 4 alkyl-S—. However, R 4 is most preferably unsubstituted and is most preferably phenyl.
- high refractive index monomers such as those according to formula (I) may be coloured due to the formation of byproducts during the synthesis of the high refractive index monomers.
- the high refractive index monomers according to formula (I) are therefore preferably purified to render them essentially colourless prior to the polymerization reaction.
- a suitable technique to purify the high refractive index monomers according to formula (I) are know to the person skilled in the art and include for example chromatography and treatment with active carbon.
- the initiator is selected from the group of thermal free radical initiators like peroxides or azo-initiators like 2,2′-Azobis(2,4-dimethylvaleronitrile).
- the initiator is selected from the group consisting of phosphine oxide photoinitiators, ketone-based photoinitiators and benzoin photoinitiators since those initiators do not give rise to the formation of gaseous byproducts.
- the initiator is a phosphine oxide photoinitiator.
- phosphine oxide photoinitiators include the IRGACURE® and DAROCURETM series of phosphine oxide initiators available from Ciba Specialty Chemicals, the LUCIRIN® series available from BASF and the ESACURE® series.
- the photoinitiators employed in the method according to the present invention can be activated by irradiation with light having a wavelength of 340 nm or more, preferably 390 nm or more. Even more preferred is that the light has a wave length of 390 nm to 500 nm (UV/VIS-irradiation; this particular region is also known in the art as “blue-light irradiation”).
- Ketone-based photoinitiators and benzoin photoinitiators are preferably used in combination with light having a wave length of 340 nm or more, preferably a wave length of 340-500 nm.
- the acrylic monomer composition comprises a crosslinker, preferably selected from the group consisting of terminally ethylenically unsaturated compounds having more than one unsaturated group, preferably a (meth)acrylate group.
- Suitable cross-linking monomers according to this fourth preferred embodiment of the present invention include:
- crosslinker is in particular preferred in that water and moisture are better retained thereby reducing glistening.
- a hydrophilic monomer such as hydroxylethyl acrylate may be used as well in combination with the single high refractive index monomer.
- the crosslinker is a multifunctional (meth)acrylate monomer which comprises at least two (meth)acrylate moieties.
- the crosslinker is represented by the general formula (II):
- R 1 is H or CH 3 ;
- R 7 is substituted or unsubstituted C 1 -C 300 alkyl, aryl, alkaryl, arylalkyl or heteroaryl;
- the substituents of R 7 are preferably selected from the group consisting of halo, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkyl-O—. C 1 -C 4 alkyl-S—, C 1 -C 4 haloalkyl-O—, C 1 -C 4 haloalkyl-S— and OH—.
- crosslinkers according to this preferred embodiment are e.g. disclosed in U.S. Pat. No. 6,653,422 which is incorporated by reference for the US patent practice.
- the cross-linking monomer is a dendritic, star or hyperbranched (co)polymer having terminal OH end groups that are partly or completely esterified with (meth)acrylic acid.
- the cross-linking monomer is a dendritic, star or hyperbranched (co)polymer having terminal OH end groups that are partly or completely esterified with (meth)acrylic acid.
- three arm to six arm polyethoxylates are known in the art wherein trimethylolpropane, pentaerythritol or trimethylol propane ethoxylate are used as the core.
- Another example is the Boltorn polymer series, in particular H20, H30 and H40 that are manufactured by Perstorp AB.
- the crosslinker is a hydrophilic crosslinker. This third preferred embodiment is preferred over the first and second preferred embodiments.
- the hydrophilic crosslinker according to the third preferred embodiment has the formula (III):
- R 1 and R 5 are independently H or CH 3 ; and o is such that the number-average molecular weight is about 200 to about 2000.
- o is 1-5.
- R 1 is CH 3 . It is also preferred that R 5 is H.
- crosslinker Generally, only one crosslinker will be present in the acrylate monomer compositions. However, combinations of crosslinkers may be desirable.
- the acrylic monomer composition may comprise the high refractive index monomer according to formula (I) and the crosslinker in various amounts which is inter alia dependent from the desired product properties, e.g. glass transition temperature, mechanical properties such as elongation.
- the acrylate monomer composition comprises at least 50 wt. % of high refractive index monomer according to formula (I), preferably at least 60 wt. %, more preferably at least 70 wt. %, even more preferably at least 80 wt. % and in particular at least 90 wt. %, based on the total weight of the acrylate monomer composition.
- the upper limit for the high refractive index monomer according to formula (I) is 99.8 wt. %.
- the acrylic monomer composition will further comprise the crosslinker in an amount of 0.1 to 20.0 wt. %, preferably 0.5 to 15.0 wt. %, based on the total weight of the acrylate monomer composition.
- the acrylate monomer composition can be polymerised directly in a mould, preferably a closed castmould.
- a mould preferably a closed castmould.
- prepolymerise the acrylate monomer composition and to finalise curing of the prepolymerised acrylate monomer composition in the mould, preferably a closed castmould.
- the polymer composition according to the present invention may contain a total of up to about 10% by weight of additional components, based on the total weight of the monomer mixture, which serve other purposes, such as UV absorbers.
- Suitable UV absorbers include benzotriazole compounds such as the Tinuvin series.
- An example is 2-(2′-hydroxy-3′-methallyl-5′-methylphenyl)benzotriazole (Tinuvin P).
- UV absorber is present in an amount of 0.1 to 5.0 wt. %, preferably 0.2 to 4.0 wt. %, based on the total weight of the acrylate monomer composition.
- the present invention also relates to an intraocular lens, preferably a flexible intraocular lens, obtainable by the method according to the invention.
- the intraocular lens has a glass transition temperature T g of less than 25° C., preferably less than 15° C., more preferably less than 10° C., which can be attained by using the hydrophobic high refractive index monomer according to formula (I).
- the IOL has a refractive index of at least 1.50, preferably at least 1.55 and more preferably at least 1.60.
- the intraocular lens has excellent mechanical properties, e.g. an elongation of at least 150%, preferably at least 200% and more preferably at least 300%.
- a suitable method for measuring elongation is for example disclosed in U.S. Pat. No. 6,653,422, incorporated by reference herein for the US patent practice.
- the HRI Monomers were synthesized as described below. Their purity was typically 95+%. Other ingredients were purchased off the shelf from outside vendors. Typically 99+% quality materials were used. Synthesis was performed in suitable laboratory glassware. Blue light irradiations for curing were performed using a suitable blue light source under a suitable atmosphere at RT (Room Temperature).
- the HRI monomer 1,3-bis(phenylthio)propan-2-yl methacrylate (M2) was formulated in the following composition under subdued light conditions to avoid premature decomposition of the photoinitiator:
- the photocurable HRI monomer containing composition as prepared previously was added to a polymeric castmould consisting of a lower and a upper half enclosing a space in the form of an IOL moulding.
- the mould was irradiated with blue light under suitable conditions for the appropriate amount of time. After opening of the mould the IOL moulding was removed and inspected for quality. It was found that the moulding consisted of an optically transparent material with the desired properties for a suitable IOL material. The moulding did not tear on folding, and returned to the original dimensions when the folding force was released. Folding marks were not visible after folding, while elongation was about 100%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/895,768 US20110021733A1 (en) | 2006-02-14 | 2010-09-30 | Intraocular lenses essentially free from glistenings |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77289506P | 2006-02-14 | 2006-02-14 | |
EP06101664.8 | 2006-02-14 | ||
EP06101664A EP1818690A1 (en) | 2006-02-14 | 2006-02-14 | Intraocular lenses essentially free from glistenings |
PCT/NL2007/050059 WO2007094665A1 (en) | 2006-02-14 | 2007-02-14 | Intraocular lenses essentially free from glistenings |
US27929008A | 2008-08-13 | 2008-08-13 | |
US12/895,768 US20110021733A1 (en) | 2006-02-14 | 2010-09-30 | Intraocular lenses essentially free from glistenings |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2007/050059 Continuation WO2007094665A1 (en) | 2006-02-14 | 2007-02-14 | Intraocular lenses essentially free from glistenings |
US27929008A Continuation | 2006-02-14 | 2008-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110021733A1 true US20110021733A1 (en) | 2011-01-27 |
Family
ID=36603681
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/279,290 Expired - Fee Related US9103964B2 (en) | 2006-02-14 | 2007-02-14 | Intraocular lenses essentially free from glistenings |
US12/895,768 Abandoned US20110021733A1 (en) | 2006-02-14 | 2010-09-30 | Intraocular lenses essentially free from glistenings |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/279,290 Expired - Fee Related US9103964B2 (en) | 2006-02-14 | 2007-02-14 | Intraocular lenses essentially free from glistenings |
Country Status (7)
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012106118A2 (en) * | 2011-01-31 | 2012-08-09 | Key Medical Technologies, Inc. | Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings |
US10159562B2 (en) | 2014-09-22 | 2018-12-25 | Kevin J. Cady | Intraocular pseudophakic contact lenses and related systems and methods |
US10299910B2 (en) | 2014-09-22 | 2019-05-28 | Kevin J. Cady | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10945832B2 (en) | 2014-09-22 | 2021-03-16 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11109957B2 (en) | 2014-09-22 | 2021-09-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11938018B2 (en) | 2014-09-22 | 2024-03-26 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858672B1 (en) | 2007-10-02 | 2010-12-28 | Alcon, Inc. | Methacrylic materials suitable for ophthalmic and otorhinolaryngological devices |
TW200916130A (en) | 2007-10-02 | 2009-04-16 | Alcon Inc | Ophthalmic and otorhinolaryngological device materials containing an alkylphenol ethoxylate |
TW200920330A (en) | 2007-10-02 | 2009-05-16 | Alcon Inc | Ophthalmic and otorhinolaryngological device materials containing an alkyl ethoxylate |
EP2427509A1 (en) * | 2009-05-07 | 2012-03-14 | Contamac Limited | Polymer composition |
GB201003404D0 (en) * | 2010-03-01 | 2010-04-14 | Contamac Ltd | High refractive index polymer composition for opthalmic applications |
EP2917178B1 (en) | 2012-11-07 | 2016-11-09 | Council of Scientific & Industrial Research | Sulphur containing high refractive index monomer |
CN105792860B (zh) * | 2013-12-04 | 2019-06-04 | 诺华股份有限公司 | 具有高折光指数和最小化的反光的软质丙烯酸材料 |
US10196470B2 (en) * | 2016-05-16 | 2019-02-05 | Benz Research And Development Corp. | Hydrophobic intraocular lens |
US20210246266A1 (en) * | 2018-06-08 | 2021-08-12 | The Regents Of The University Of Colorado, A Body Corporate | High dynamic range two-stage photopolymers |
CN113321763A (zh) * | 2021-08-02 | 2021-08-31 | 微创视神医疗科技(上海)有限公司 | 一种聚合物及其应用、以及眼科医疗器材 |
CN115701428A (zh) * | 2021-08-02 | 2023-02-10 | 上海发微医用材料有限公司 | 一种光引发剂及其应用 |
CN115385834B (zh) * | 2022-08-15 | 2023-11-03 | 中国科学院理化技术研究所 | 一种高折射率树枝状(甲基)丙烯酸酯类单体及其制备方法和应用 |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2005A (en) * | 1841-03-16 | Improvement in the manner of constructing molds for casting butt-hinges | ||
US5132430A (en) * | 1991-06-26 | 1992-07-21 | Polaroid Corporation | High refractive index polymers |
US5290892A (en) * | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
US5331073A (en) * | 1992-11-09 | 1994-07-19 | Allergan, Inc. | Polymeric compositions and intraocular lenses made from same |
US5693095A (en) * | 1995-06-07 | 1997-12-02 | Alcon Laboratories, Inc. | High refractive index ophthalmic lens materials |
US5945498A (en) * | 1995-04-04 | 1999-08-31 | Novartis Ag | Polysiloxane-comprising perfluoroalkyl ethers and the preparation and use thereof |
US6015842A (en) * | 1997-08-07 | 2000-01-18 | Alcon Laboratories, Inc. | Method of preparing foldable hydrophilic ophthalmic device materials |
US6140438A (en) * | 1997-08-20 | 2000-10-31 | Menicon Co., Ltd. | Soft intraocular lens material |
US6326448B1 (en) * | 1997-08-20 | 2001-12-04 | Menicon Co., Ltd. | Soft intraocular lens material |
US6329485B1 (en) * | 1998-12-11 | 2001-12-11 | Bausch & Lomb Incorporated | High refractive index hydrogel compositions for ophthalmic implants |
US20030130460A1 (en) * | 1999-09-07 | 2003-07-10 | Charles Freeman | Foldable ophthalmic and otorhinolaryngological device materials |
US20030224250A1 (en) * | 2002-05-29 | 2003-12-04 | Songvit Setthachayanon | Novel exceptional high reflective index photoactive compound for optical applications |
US6833391B1 (en) * | 2003-05-27 | 2004-12-21 | General Electric Company | Curable (meth)acrylate compositions |
US20050055090A1 (en) * | 2003-09-08 | 2005-03-10 | Yu-Chin Lai | Process for manufacturing intraocular lenses with blue light absorption characteristics |
US20070010883A1 (en) * | 1999-04-12 | 2007-01-11 | Khalid Mentak | Water plasticized high refractive index polymer for ophthalmic applications |
WO2007062864A2 (de) * | 2005-12-01 | 2007-06-07 | Coronis Gmbh | Polymerzusammensetzung mit hohem brechungsindex |
US7297160B2 (en) * | 2005-06-15 | 2007-11-20 | Bausch & Lomb Incorporated | High refractive-index, hydrophilic, arylsiloxy-containing macromonomers and polymers, and ophthalmic devices comprising such polymers |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2094796T3 (es) | 1990-11-07 | 1997-02-01 | Nestle Sa | Polimeros y su uso para lentes oftalmicas. |
US6353069B1 (en) * | 1998-04-15 | 2002-03-05 | Alcon Manufacturing, Ltd. | High refractive index ophthalmic device materials |
AU741716B2 (en) * | 1998-04-15 | 2001-12-06 | Alcon Laboratories, Inc. | High refractive index ophthalmic device materials |
US7271283B2 (en) | 2003-08-29 | 2007-09-18 | General Electric Company | High refractive index, UV-curable monomers and coating compositions prepared therefrom |
-
2006
- 2006-02-14 EP EP06101664A patent/EP1818690A1/en not_active Withdrawn
-
2007
- 2007-02-14 JP JP2008554167A patent/JP2009526561A/ja active Pending
- 2007-02-14 EP EP07715879A patent/EP1984761B1/en not_active Expired - Fee Related
- 2007-02-14 CN CN 201110143888 patent/CN102250282B/zh not_active Expired - Fee Related
- 2007-02-14 CN CN 200780008412 patent/CN101401012A/zh active Pending
- 2007-02-14 ES ES07715879T patent/ES2362134T3/es active Active
- 2007-02-14 WO PCT/NL2007/050059 patent/WO2007094665A1/en active Application Filing
- 2007-02-14 US US12/279,290 patent/US9103964B2/en not_active Expired - Fee Related
- 2007-02-14 DE DE602007013360T patent/DE602007013360D1/de active Active
-
2010
- 2010-09-30 US US12/895,768 patent/US20110021733A1/en not_active Abandoned
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2005A (en) * | 1841-03-16 | Improvement in the manner of constructing molds for casting butt-hinges | ||
US5290892A (en) * | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
US5861031A (en) * | 1990-11-07 | 1999-01-19 | Nestle, S.A. | Intraocular lens from arylalkyl(meth)acrylate polymer(s) |
US5132430A (en) * | 1991-06-26 | 1992-07-21 | Polaroid Corporation | High refractive index polymers |
US5331073A (en) * | 1992-11-09 | 1994-07-19 | Allergan, Inc. | Polymeric compositions and intraocular lenses made from same |
US5945498A (en) * | 1995-04-04 | 1999-08-31 | Novartis Ag | Polysiloxane-comprising perfluoroalkyl ethers and the preparation and use thereof |
US5693095A (en) * | 1995-06-07 | 1997-12-02 | Alcon Laboratories, Inc. | High refractive index ophthalmic lens materials |
US6015842A (en) * | 1997-08-07 | 2000-01-18 | Alcon Laboratories, Inc. | Method of preparing foldable hydrophilic ophthalmic device materials |
US6140438A (en) * | 1997-08-20 | 2000-10-31 | Menicon Co., Ltd. | Soft intraocular lens material |
US6326448B1 (en) * | 1997-08-20 | 2001-12-04 | Menicon Co., Ltd. | Soft intraocular lens material |
US6329485B1 (en) * | 1998-12-11 | 2001-12-11 | Bausch & Lomb Incorporated | High refractive index hydrogel compositions for ophthalmic implants |
US6657032B2 (en) * | 1998-12-11 | 2003-12-02 | Bausch & Lomb Incorporated | High refractive index hydrogel compositions for ophthalmic implants |
US20070010883A1 (en) * | 1999-04-12 | 2007-01-11 | Khalid Mentak | Water plasticized high refractive index polymer for ophthalmic applications |
US20030130460A1 (en) * | 1999-09-07 | 2003-07-10 | Charles Freeman | Foldable ophthalmic and otorhinolaryngological device materials |
US6653422B2 (en) * | 1999-09-07 | 2003-11-25 | Alcon Universal Ltd. | Foldable ophthalmic and otorhinolaryngological device materials |
US20030224250A1 (en) * | 2002-05-29 | 2003-12-04 | Songvit Setthachayanon | Novel exceptional high reflective index photoactive compound for optical applications |
US6833391B1 (en) * | 2003-05-27 | 2004-12-21 | General Electric Company | Curable (meth)acrylate compositions |
US20050055090A1 (en) * | 2003-09-08 | 2005-03-10 | Yu-Chin Lai | Process for manufacturing intraocular lenses with blue light absorption characteristics |
US7297160B2 (en) * | 2005-06-15 | 2007-11-20 | Bausch & Lomb Incorporated | High refractive-index, hydrophilic, arylsiloxy-containing macromonomers and polymers, and ophthalmic devices comprising such polymers |
WO2007062864A2 (de) * | 2005-12-01 | 2007-06-07 | Coronis Gmbh | Polymerzusammensetzung mit hohem brechungsindex |
US20090247661A1 (en) * | 2005-12-01 | 2009-10-01 | Coronis Gmbh | Polymer composition having a high refractive index |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012106118A2 (en) * | 2011-01-31 | 2012-08-09 | Key Medical Technologies, Inc. | Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings |
WO2012106118A3 (en) * | 2011-01-31 | 2012-10-11 | Key Medical Technologies, Inc. | Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings |
US8455572B2 (en) | 2011-01-31 | 2013-06-04 | Key Medical Technologies, Inc. | Method of making ophthalmic devices and components thereof from hydrophobic acrylic (HA) polymers with reduced or eliminated glistenings |
US10159562B2 (en) | 2014-09-22 | 2018-12-25 | Kevin J. Cady | Intraocular pseudophakic contact lenses and related systems and methods |
US10299910B2 (en) | 2014-09-22 | 2019-05-28 | Kevin J. Cady | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10842614B2 (en) | 2014-09-22 | 2020-11-24 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lenses and related systems and methods |
US10945832B2 (en) | 2014-09-22 | 2021-03-16 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11109957B2 (en) | 2014-09-22 | 2021-09-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11432921B2 (en) | 2014-09-22 | 2022-09-06 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lenses and related systems and methods |
US11571293B2 (en) | 2014-09-22 | 2023-02-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11583386B2 (en) | 2014-09-22 | 2023-02-21 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11903818B2 (en) | 2014-09-22 | 2024-02-20 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lenses and related systems and methods |
US11938018B2 (en) | 2014-09-22 | 2024-03-26 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens (IOPCL) for treating age-related macular degeneration (AMD) or other eye disorders |
Also Published As
Publication number | Publication date |
---|---|
EP1984761B1 (en) | 2011-03-23 |
ES2362134T3 (es) | 2011-06-28 |
US20090054978A1 (en) | 2009-02-26 |
JP2009526561A (ja) | 2009-07-23 |
CN102250282B (zh) | 2013-04-03 |
US9103964B2 (en) | 2015-08-11 |
EP1984761A1 (en) | 2008-10-29 |
CN101401012A (zh) | 2009-04-01 |
DE602007013360D1 (de) | 2011-05-05 |
WO2007094665A1 (en) | 2007-08-23 |
EP1818690A1 (en) | 2007-08-15 |
CN102250282A (zh) | 2011-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9103964B2 (en) | Intraocular lenses essentially free from glistenings | |
EP2582409B1 (en) | High refractive index, acrylic ophthalmic device materials with reduced glistenings | |
EP2443485B1 (en) | Biomedical devices | |
CN110382473B (zh) | 用于光学活性装置的疏水化合物 | |
CN110300747B (zh) | 用于光学活性装置的双型化合物 | |
US6313187B2 (en) | High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method | |
US7781496B2 (en) | High refractive-index, hydrophilic monomers and polymers, and ophthalmic devices comprising such polymers | |
CA2588528A1 (en) | Copolymerizable methine and anthraquinone compounds and articles containing them | |
JP2003508605A (ja) | 眼科および耳鼻咽喉科用の装置材料 | |
JP6166479B2 (ja) | 高い屈折率および最小限のグリスニングを有する軟質アクリル材料 | |
KR20010030994A (ko) | 4성분 공중합체 및 이것으로 제조한 안구용 렌즈 | |
US7923520B2 (en) | High refractive index monomers and (co)polymers prepared therefrom | |
JPH10195324A (ja) | 反応性黄色染料およびそれを含む眼用レンズ | |
US20160194424A1 (en) | Monomers for use in a polymerizable composition and high refractive index polymer for opthalmic applications | |
WO2019228224A1 (zh) | 聚合物材料以及眼内透镜 | |
EP1381636A2 (en) | Polymer composition for intraocular lens | |
CN101405253B (zh) | 高折射率单体及由其制得的聚合物/共聚物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: OCULENTIS HOLDING B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PROCORNEA HOLDING B.V.;REEL/FRAME:031493/0709 Effective date: 20130829 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |